ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	JPRN
Last refreshed on:	17 October 2023
Main ID:	JPRN-UMIN000026690
Date of registration:	24/03/2017
Prospective Registration:	No
Primary sponsor:	Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine
Public title:	Prediction of effect of chemotherapy by comprehensive T cell receptor (TCR) analysis of colon cancer tumor infiltrating lymphocytes and effect of anti-tumor specific immunity induction
Scientific title:	Prediction of effect of chemotherapy by comprehensive T cell receptor (TCR) analysis of colon cancer tumor infiltrating lymphocytes and effect of anti-tumor specific immunity induction - Prediction of effect of chemotherapy by comprehensive T cell receptor (TCR) analysis of colon cancer tumor infiltrating lymphocytes and effect of anti-tumor specific immunity induction
Date of first enrolment:	2015/04/14
Target sample size:	40
Recruitment status:	Complete: follow-up complete
URL:	https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030643
Study type:	Observational
Study design:	Not selected Not selected
Phase:	Not selected

Countries of recruitment
Japan

Contacts

Name:	Hiroaki Nagano
Address:	1-1-1 Minamikogushi 2-chome, Ube-shi, Yamaguchi, JAPAN Japan
Telephone:	0836-22-2264
Email:	hnagano@yamaguchi-u.ac.jp
Affiliation:	Yamaguchi University Graduate School of Medicine Department of Gastroenterological, Breast and Endocrine Surgery

Name:	Shinobu Tomochika
Address:	1-1-1 Minamikogushi 2-chome, Ube-shi, Yamaguchi, JAPAN 7558505 Japan
Telephone:	0836-22-2264
Email:	bu-shino@yamaguchi-u.ac.jp
Affiliation:	Yamaguchi University Graduate School of Medicine Department of Gastroenterological, Breast and Endocrine Surgery

Key inclusion & exclusion criteria

Inclusion criteria:
Exclusion criteria: Patients who did not obtain consent to this study

Age minimum: 20years-old
Age maximum: Not applicable
Gender: Male and Female

Health Condition(s) or Problem(s) studied

colorectal cancer

Intervention(s)

Primary Outcome(s)

Identification of biomarkers involved in the efficacy of Cetuximab

Secondary Outcome(s)

Secondary ID(s)

Source(s) of Monetary Support

Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine

Secondary Sponsor(s)

Ethics review

Status: YES
Approval date: 24/06/2015
Contact:

me223@yamaguchi-u.ac.jp

Center For Clinical Research, Yamaguchi University Hospital

0836222428

me223@yamaguchi-u.ac.jp

Results

Results available:	Yes
Date Posted:
Date Completed:	31/03/2023
URL:

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.